Biological Dynamics, OHSU Partner to Validate Pancreatic Cancer Early Detection Test
The collaboration will involve testing 520 samples from pancreatic cancer patients and healthy individuals using the exosome-isolating ExoVita Pancreas assay.
Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement
The companies aim to use Caris' genomic and transcriptomic testing to identify biomarkers that can improve chances of success for the novel drug.
Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients
The firm will evaluate its epigenomic liquid biopsy test to detect pancreatic cancer among patients considered high-risk for the disease due to their diabetes.
Curetis to Assist BioVersys' Antibacterial Drug Trial With Unyvero Platform
BioVersys will use the Unyvero HPN in its drug trial to test hospitalized trial candidates for antibiotic-resistant Acinetobacter infections.
Singapore Institutions Launch Program to Diagnose, Treat EBV-Associated Nasopharyngeal Cancer
The program, funded by Singapore's National Research Foundation, aims to identify Epstein-Barr virus strains associated with NPC in Southeast Asian populations.